CLOSE
MENU
Chordia Therapeutics Inc.
Investor Relations
Investor Relations
サブ-ナビゲーション
Company
Science/Pipleline
News
現在位置:
Investor Relations
Management Policies
Financial Information
IR Library
Stock Information
IR Calender
IR News
IR FAQ
Disclaimer
Career
Contact
Privacy Policy
Term of use
Sitemap
Investor Relations
Top Message
Financial Highlights
IR News
Mar 18, 2026
Notice of the First Patient Dosed in the Initial Expansion Cohort of rogocekib
（267KB）
Mar 17, 2026
Notice of Publication of a Joint Research Paper with Kyoto University on CDK12 Inhibitor CTX-439
（403KB）
Feb 26, 2026
Notice Regarding the Initiation of Expansion Cohorts for rogocekib
（304KB）
Feb 18, 2026
(Delayed)Notice Regarding Execution of a Termination Agreement for the CTX-177(ONO-7018) License Agreement
（290KB）
Feb 03, 2026
Notice Concerning Change of Major Shereholder
（246KB）
IR News
IR Calendar
14-Jul-26（scheduled）
Announcement of 2Q Financial results of FY2025（scheduled）
Latest financial statements
複製用パーツ：20XX年X月期 第X四半期 （英文：FY20XX QX）
FY2025
（0KB）
FY2025 4Q
Fiscal year ended August 2025 Financial Results (Transcript)
（6,773KB）
FY2025 2Q
Financial Results (Transcript)
（3,003KB）
FY2024
Fiscal year ended August 2024 Financial Results (Transcript)
（2,714KB）
FY2026 (1Q)
Non-consolidated Financial Results for the Three Months Ended November 30, 2025
（441KB）
FY2025
Non-consolidated Financial Results for the Fiscal Year Ended August 31, 2025 [Japanese GAAP]
（658KB）
Fiscal year ended August 2025 Financial Results Presentation
（1,011KB）
FY2025 (3Q)
Non-consolidated Financial Results for the Nine Months Ended May 31, 2025 [Japanese GAAP]
（440KB）
FY2025 (2Q)
Non-consolidated Financial Results for the Six Months Ended February 28, 2025 [Japanese GAAP]
（442KB）
For 2nd quarter FY8 2025 Financial Results Presentation
（1,132KB）
FY2025 (1Q)
Non-consolidated Financial Results for the Three Months Ended November 30, 2024 [Japanese GAAP]
（432KB）
FY2024
Non-consolidated Financial Results for the Fiscal Year Ended August 31, 2024 [Japanese GAAP]
（538KB）
Fiscal year ended August 2024 Financial Results Presentation
（1,465KB）
FY2024 (3Q)
Non-consolidated Financial Results for the Nine Months Ended May 31, 2024 [Japanese GAAP]
（348KB）
Management Policies
Top Message
Discloser Policy
Corporate Governance
Financial Information
Financial Highlights
Financial Indicators
Cash Flow
IR Library
Financial Results
Corporate Research Report
Stock Information
General Meeting of Shareholders
Stock Price
IR Calender
Disclaimer
ページの先頭へ
ページの先頭へ
menu
gnavi-box
複製用パーツ：20XX年X月期 第X四半期 （英文：FY20XX QX）
FY2025 4Q
FY2025 2Q
FY2024